UK markets closed

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
113,500.00-2,200.00 (-1.90%)
At close: 03:30PM KST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
49,706,128
105,365,808
186,060,277
232,288,414
Other short-term investments
5,800,000
6,940,109
16,874,812
23,210,000
Total cash
55,506,128
112,305,916
202,935,089
255,498,414
Net receivables
436,956,740
394,154,670
413,791,000
402,088,272
Inventory
516,245,342
442,408,248
454,976,365
437,071,446
Other current assets
-0.87
0.42
26,000
-0.68
Total current assets
1,039,149,088
980,437,889
1,095,620,834
1,132,043,319
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,360,318,738
1,293,377,404
1,230,503,382
1,048,457,996
Accumulated depreciation
-407,616,000
-362,555,000
-330,656,000
-297,359,000
Net property, plant and equipment
952,702,738
930,822,404
899,847,381
751,098,996
Goodwill
142,475,000
142,475,000
142,475,000
10,065,000
Intangible assets
195,406,072
169,088,218
134,930,845
99,498,983
Other long-term assets
-4.4
-0.58
0.99
-0.13
Total non-current assets
1,604,164,830
1,545,099,192
1,366,523,898
1,019,356,275
Total assets
2,643,313,917
2,525,537,081
2,462,144,732
2,151,399,594
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
518,260,119
187,416,000
225,374,774
294,375,000
Accounts payable
143,815,696
121,270,008
119,540,920
134,784,701
Other current liabilities
0.59
0.09
0.75
0.08
Total current liabilities
868,916,639
540,738,447
552,882,863
589,402,990
Non-current liabilities
Long-term debt
84,890,698
278,796,832
280,343,368
194,160,243
Deferred tax liabilities
2,213,056
1,357,817
1,869,377
1,876,361
Deferred revenues
15,884,214
22,693,024
24,589,660
13,599,849
Other long-term liabilities
-0.2
0.95
0.59
0.26
Total non-current liabilities
234,533,969
418,156,703
409,504,851
292,690,860
Total liabilities
1,103,450,608
958,895,150
962,387,715
882,093,850
Stockholders' equity
Common stock
58,432,690
58,432,690
58,432,690
58,432,690
Retained earnings
872,988,970
903,467,121
867,352,642
757,278,401
Total stockholders' equity
1,300,236,294
1,328,122,429
1,274,770,514
1,118,523,671
Total liabilities and stockholders' equity
2,643,313,917
2,525,537,081
2,462,144,732
2,151,399,594